G03XB01 • mifepristone + misoprostol • Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Progesterone receptor modulators
The combination of Mifepristonum + Misoprostolum is used for terminating early pregnancies, typically up to 10 weeks of gestation. Mifepristonum blocks the effects of progesterone, while Misoprostolum stimulates uterine contractions, completing the medical abortion process.
The medications are administered orally or vaginally, according to a specific regimen, under medical supervision. This combination is highly effective in terminating pregnancies.
Side effects may include nausea, vomiting, abdominal cramps, diarrhea, and vaginal bleeding. In rare cases, severe complications such as infections or hemorrhage may occur. Close monitoring is essential.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Use must occur exclusively under medical supervision.
Substance: mifepristone + misoprostol
Date of last drug list: 01-07-2015
Commercial code: W61402002
Concentration: 600mg / 400mcg
Pharmaceutical form: tablets
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).